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Umbilical artery catheterization has proven useful
in the treatment of critically ill neonates. The need for
accurate pressure monitoring, frequent blood draws,
and arterial blood gases requires access into the arter-
ial system of infants. Although the placement of
umbilical arterial lines has become more common, a
considerable number of complications have been
reported. Although some authors advocate conserva-
tive management,4 the treatment of clinically relevant
aortorenal thrombosis has been primarily surgical.5-7
Therapy is designed to restore blood flow before tis-
sue loss. However, the fragile nature of the arterial
wall, coupled with critical illness in the neonate, cre-
ates an unfavorable environment for standard inter-
ventions. Thrombolytic therapy is currently an accept-
able treatment in select cases of acute arterial occlu-
sions.8-10 Occlusions that respond favorably to
thrombolytic therapy include acute thromboses (less
than 14 days of symptoms) and those that can be
crossed with a guidewire or catheter. The less invasive
nature of thrombolytic therapy makes this a potential
alternative to high-risk surgical procedures. The use
of the umbilical artery as an access site to allow
catheter-directed thrombolytic therapy for the treat-
ment of renal artery thrombosis caused by umbilical
arterial catheterization was studied.
CASE REPORT
S.M. was born at a gestational age of 41 and 4⁄7 weeks
to a 41-year-old woman whose pregnancy was complicat-
ed by pregnancy-induced hypertension. The delivery was
complicated by a meconium aspiration, resulting in respi-
ratory compromise. He was resuscitated and then trans-
ferred to the neonatal intensive care unit. Pulmonary
hypertension developed and persisted, despite maximal
treatment. A 5F umbilical artery catheter (Argyle, St
Louis, Mo) was placed at the level of the third lumbar disc,
and he was further resuscitated.
When the neonate was 5 days old, the umbilical artery
catheter was removed. The next day, he was found to have
systemic hypertension (Fig 1) and microscopic hematuria.
Intravenous hydralazine therapy was initiated. Kidneys of
equal size, without evidence of arterial flow to the right kid-
ney, were demonstrated by means of a renal duplex scan,
obtained when the neonate was 9 days of age; however,
venous flow was evident, perhaps indicative of a more viable
situation. A diethylenetriamine pentaacetic acid–technetium
renal scan confirmed the absence of right renal function.
Although interventions were considered at this time, none
were undertaken because involved parties felt the hyperten-
sion could be medically controlled.
The development of pulmonary edema prompted a
more aggressive approach to the management of his hyper-
tension. Nitroprusside, furosemide, and enalapril were
administered in a sequential fashion. Although his cardiac
failure stabilized, he remained hypertensive. We elected to
perform an angiogram, using the umbilical artery as an
access site, with the intention of treating the renal artery
thrombosis with catheter-directed thrombolytic therapy.
The procedure was performed under general anesthesia
on day 15 of the neonate’s life. The abdomen was prepared
and draped, and the left umbilical artery was exposed
through a periumbilical incision. Proximal and distal control
were obtained, and an arteriotomy was made (Fig 2). A
0.035-in hydrophilic wire (Cook Radiology, Bloomington,
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Ind) was used to enter the thoracic aorta. A 4F sheath (Cook
Radiology, Bloomington, Ind) was placed without difficulty
and was followed by a 4F pigtail catheter (Angiodynamics,
Queensbury, NY). An angiogram was obtained (Fig 3), by
means of which a nearly occluding thrombus isolated to the
right renal artery was depicted. The right renal orifice was
selectively cannulated with a 4F Berenstein catheter, and an
0.035-in infusion wire (MTI, San Diego, Calif) was placed
through the thrombus. Pulse lysis was attempted with a total
dose of 125,000 units of urokinase over 10 minutes. There
was no appreciable change in the amount of thrombus.
Catheter-directed urokinase therapy was initiated at a rate of
192 U/min via the infusion wire. This dose was calculated
based on a standard adult dose of 4000 U/min9 in patients
with an approximate blood volume of 4 liters. Heparin was
administered at a rate of 70 U/h, to prevent pericatheter
thrombus formation. Careful attention was given to ade-
quate management of the hypertension during the lytic infu-
sion to minimize the risk of cerebral hemorrhage (Fig 1).
Four hours after the initiation of urokinase therapy, complete
thrombus dissolution was shown by means of a second
angiogram (Fig 3).
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Fig 1. The neonate was born without evidence of hypertension. After the insertion of the
umbilical artery catheter, systemic hypertension developed. This was initially treated with
hydralazine (A). Nitroprusside (B) and captopril therapy (C) furosemide. Catheter-directed
thrombolysis (D) was performed while the hypertension was controlled after an episode of
congestive heart failure.
Fig 2. A periumbilical incision allowed rapid access to the umbilical artery. Proximal and distal
control was established with vessel loops before the insertion of a 4F sheath. After diagnostic
angiography, a coaxial system was introduced to allow catheter-directed thrombolytic therapy.
One day after the procedure, the patient was nor-
motensive; all antihypertensive medications were discon-
tinued. Symmetrical renal arterial flow was demonstrated
by means of duplex ultrasound scan. His creatinine level
normalized. Normal function of the left kidney was shown
by means of a renal scan, whereas the right kidney was
functioning at 60% of expected levels. The patient
remained stable and was discharged home on postproce-
dure day 10. Approximately 1 month after discharge,
enalapril was reinstituted to control moderate systolic
hypertension. At that time, good flow to the right kidney
was revealed by means of duplex scan examination. At 4
months, the absence of flow to the right kidney in con-
junction with minimal renal function was demonstrated by
means of scheduled ultrasonographic and renal scans.
DISCUSSION
The current use of umbilical artery catheteriza-
tion is associated with a low morbidity rate. This
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Fig 3. A, Linear thrombus is isolated to the right renal artery. B, This was followed by place-
ment of an infusion wire through the thrombus. C, Complete dissolution of the thrombus,
with markedly improved blood flow to the renal parenchyma, was demonstrated by means of
an aortogram obtained 4 hours after the institution of thrombolytic therapy.
contrasts with historical reports of a high incidence
of acute complication15 and radiographic evidence
of clinically silent pericatheter thrombus formation
in most patients with umbilical artery lines.1 More
recent studies cite an incidence rate of clinically sig-
nificant thrombus formation of 1% to 10%.2,7
Angiographic access in neonates has historically
been associated with significant complications involv-
ing the femoral arteries. Although the establishment
of percutaneous access is quite feasible, the size of the
artery compared with the size of interventional
devices makes neonates prone to thrombus forma-
tion. Intimal injury, the age of the neonate, and the
presence of spasm have all been implicated in the for-
mation of neonatal thrombotic complications.13,20
The use of systemic heparinization during interven-
tional procedures was shown to diminish, but not
eliminate, the incidence of arterial thrombosis.21 The
involuting umbilical artery provides access to the
arterial system without the need to puncture the
femoral artery. Although frequently used for moni-
toring devices, this route has not been well-explored
for catheter-directed therapies. The small periumbili-
cal incision and minimal dissection required to obtain
vascular control allows the artery to be ligated after
the procedure.
Thrombus formation was demonstrated by
means of a prospective evaluation in approximately
85% of all neonates after umbilical artery catheter
placement.1 However, the incidence of clinically sig-
nificant thrombus formation ranges from 3% to
33%.2,3 Various types of indwelling catheters have
been tested in vitro and in vivo.6 Silicone rubber was
noted to be less thrombogenic than polyethylene,
polyurethane, or Teflon.16 The presence or absence
of side-holes and the position of the catheter within
the aorta were found to significantly contribute to
de novo thrombus formation.17 There is no evi-
dence to suggest that the type of infusion or fre-
quency of catheter manipulations relate to thrombus
formation.6 Low cardiac outputs, hypercoaguability,
and small vessels provide conditions favoring throm-
bus formation.
The use of thrombolytic therapy in newborns has
been investigated. The systemic administration of a
variety of agents has not been successful.22-24
Intermediate results were obtained with early meth-
ods of local thrombolytic agent infusions in the set-
ting of aortic thrombosis.25,26 The limited success of
this therapy has been attributed to many factors,
including the immaturity of the neonatal fibrinolytic
system and lower levels of circulating plasminogen in
this age group.6 Low profile, more efficient infusion
catheters and wires, new thrombolytic agents, and
the use of fresh-frozen plasma may allow the provi-
sion of less-invasive therapy with minimal morbidity
and mortality.
Lysis was achieved in S.M. after a 4-hour infu-
sion of urokinase. The rapid clot dissolution is likely
attributable to the volume and age of the thrombus,
as well as the local administration of an appropriate
amount of thrombolytic agent.
Successful therapy was evidenced by the decrease
in the serum creatinine level and the discontinuation
of all antihypertensive and diuretic medications.
Although early evidence of bilateral renal function
approached equality, a renal size discrepancy and a sig-
nificant functional deficit was demonstrated by means
of re-evaluation at 4 months. These findings may be
attributed to the initial insult, or rethrombosis of the
microcirculation, possibly caused by the institution of
an angiotensin-converting enzyme inhibitor at 1
month of age. The follow-up plans on the child
involve medically managing his hypertension. We
assume that, because there is minimal to no function
of the right kidney, a more aggressive approach is not
warranted in the absence of intractable hypertension.
The use of the umbilical artery as an access site
to the central arterial system of neonates avoids
complications associated with femoral artery punc-
ture and cutdown. Catheter-directed thrombolytic
therapy in the neonate is feasible and effective when
properly managed. The diminished morbidity and
mortality rates of less invasive interventions will
allow earlier and more aggressive treatments, thus
increasing the potential for renal salvage and avoid-
ing the need for long-term antihypertensive therapy.
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